Seah LIm

Inga fler pågående positioner

Förmögenhet: 41 474 $ per 2026-06-30

68 år

Consumer Services

Health Technology

Profil

Seah H.
LIm is the founder of Medicovestor, Inc. Currently, Dr. LIm is the Director of the Adult Sickle Cell Program at SUNY Upstate Medical University since 2021.
Formerly, Dr. LIm was the Chief Executive Officer of Medicovestor Bio Plc and served as an Independent Director at Emmaus Life Sciences, Inc. from 2022 to 2024.
Dr. LIm earned doctorates from the University of Aberdeen and The University of Wales.

Kända innehav i offentliga företag

Företag	Datum	Antal aktier	Värdering	Värderingsdatum
EMMAUS LIFE SCIENCES, INC. 5,91 %	2025-03-15	4 147 426 ( 5,91 % )	41 474 $	2026-06-30

Aktiva positioner av Seah LIm

Företag	Position	Start
SUNY Upstate Medical University SUNY Upstate Medical University Other Consumer ServicesConsumer Services Functions as a College/University	Företagsledare/Principal	2021-10-01

Alla aktiva positioner av Seah LIm

Tidigare kända positioner av Seah LIm

Företag	Position	Slut
EMMAUS LIFE SCIENCES, INC.	Direktör/Styrelseledamot	2024-11-04
Medicovestor Bio Plc	Verkställande Direktör	-

Se detaljerna i Seah LIms erfarenhet

Seah LIms utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Seah LIms erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	5
University of Aberdeen University of Aberdeen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
SUNY Upstate Medical University SUNY Upstate Medical University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
The University of Wales The University of Wales Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Emmaus Life Sciences, Inc. Emmaus Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments and therapies for rare diseases	Health Technology
Medicovestor Bio Plc